OneSource Specialty Pharma Ltd News

Onesource Specialty Pharma tanks 18% on weak Q3; what should investors do?

In Q3, the company's net loss widened to ₹88.7 crore, as compared to ₹68.8 crore, year-on-year (Y-o-Y). Its revenue from operations stood at ₹290.3 crore, down 26 per cent Y-o-Y